Drug Class
CAR T-cell therapy
Type
brand
Active Ingredient
idecabtagene vicleucel
📋Overview
Abecma is a type of cell-based therapy known as a CAR T-cell therapy. It is designed to modify a patient's own immune cells to help recognize and attack certain cancer cells. Abecma is primarily associated with the treatment of multiple myeloma, a cancer of plasma cells in the bone marrow. This therapy represents an advanced approach in the field of immuno-oncology.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Abecma
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.